MEI Pharma Reports Second Quarter Fiscal Year 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
MEI Pharma (MEIP) Reports Q2 EPS of $0.32
February 8, 2017 8:38 AM ESTMEI Pharma (NASDAQ: MEIP) reported Q2 EPS of $0.32, versus ($0.15) reported last year. Revenue for the quarter came in at $17.1 million, versus $0 reported last year.
For earnings history and earnings-related data on MEI Pharma (MEIP) click here.
... More